FDA OKs New Therapy for Some Hemophilia Patients - NBC Chicago
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    processing...

    NEWSLETTERS

    FDA OKs New Therapy for Some Hemophilia Patients
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Woman, 93, Rescued From Camp Fire by Her Garbageman

    [NATL] Woman, 93, Rescued From Camp Fire by Her Garbageman

    Margaret Newsum, 93, had no idea that the Camp Fire was rapidly approaching her Magalia home until her caretaker left for the day and she turned on the television. She was quickly rescued by her friend Dane Ray Cummings, who decided to break company policy and rescue Newsum with his Waste Management truck. KCRA reports.

    (Published Tuesday, Nov. 13, 2018)

    Hemophilia mostly affects males.